Pharmaceutical preparation for percutaneous administration conta

Details Pharmaceutical preparation for percutaneous administration conta Pharmaceutical preparation for percutaneous administration conta

1989-10-27

1991-08-20

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514547, 514552, 514929, A61K 3155, A61K 31225, A61K 3123

Patent

active

050414372

ABSTRACT:
A pharmaceutical composition comprises (a) a pharmacologically effective amount of bunazosin or a pharmacologically acceptable salt thereof and (b) a monoglyceride of a fatty acid having 8 to 12 carbon atoms and/or a lactic acid ester of an aliphatic alcohol having 12 to 18 carbon atoms and is improved in percutaneous administration. ##STR1##

REFERENCES:
patent: 4377581 (1983-03-01), Hess et al.
patent: 4925837 (1990-05-01), Cavaero et al.
J. Pharm. Pharmacol. vol. 39, 1987, pp. 399-400, A. Kato et al., "Effect of Egg Yolk Lecithin on Transdermal Delivery of Bunazosin Hydrochloride".
Chemical Abstracts, vol. 111, No. 12, No. 102753a (1989).

Affiliated with

Also associated with

Rating

Pharmaceutical preparation for percutaneous administration conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical preparation for percutaneous administration conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation for percutaneous administration conta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1008078